A small family business with large holdings

How promising companies
become successful.

Schörling’s role as an active owner is to create opportunities for companies to develop and become best in class. We believe in a long-term perspective, being cost-conscious, and building close relationships. And last, but not least, we believe in having focus on results.

→

AAK
Absolent
Anticimex
Assa Abloy
Greenbridge
Hexagon
Hexpol
Nibe
Securitas

The companies we invest in

Schörling is an active owner specializing in industrial businesses with roots in Scandinavia. These companies are globally widespread and most of their sales take place outside of Sweden. They all share two similarities: great development potential from the beginning, and growth over time into world leaders in their respective niches.

Our Holdings

→

The relationships we build

To Schörling, people are and have always been the most important factor. In our team, our network and the companies we invest in. We surround ourselves with individuals with different competencies, experiences and personalities. Together, we share the same values and are driven by our ambition to develop sound businesses that become best in class. The Schörling board consists of a group of carefully selected people who all contribute with their substantial and diverse experience. They know our companies inside out.

About Us

→

The Schörling Foundation

The Schörling Foundation was instituted by the Schörling family in 2014. The Foundation is run without profit and has its financial base in a donation made by Melker Schörling, the founder of the company.

The Foundation’s purpose is to promote scientific education and research. This is done by supporting current and urgent projects run by institutes or individual researchers. In addition, the Foundation supports projects, organizations and individuals who encourage the development of children and young people.

"The Swedish FTD Initiative" is a research project founded and supported by the Foundation. The goal is to strengthen the collaboration within research so that one day effective treatment against FTD (frontotemporal dementia) will be offered. Two professors from Karolinska Institutet and two professors from KTH have together had the opportunity to build a consortium for research on the disease over several years.

In the beginning of 2022, The Schörling Foundation decided to grant funding to Karolinska Institutet, Department of Molecular Medicine and Surgery, Research Group Thoracic Surgery. The purpose of the donation is to enforce the devlopment of cardiothoracic surgical technology and methodology and the related reserach by the group.

News & Reports

All News & Reports

→

Invitation to teleconference and webcast with presentation of NIBE Industrier AB’s Interim Report for the second quarter 2025

Nibe

—

2025

NIBE Industrier AB (publ) will publish its Interim Q2 report on Friday, August 22, 2025, at 08:00 AM (CET). In connection with the release of the report, the Company will hold a teleconference and webcast presentation for investors and analysts.

Securitas AB Interim Report Q2 2025 | January–June

Securitas

—

2025

APRIL–JUNE 2025 · Total sales MSEK 38 564 (40 638) · Organic sales growth 5 percent (5) · Real sales growth within technology and solutions 4 percent (7) · Operating income before amortization MSEK 2 798 (2 801) · Operating margin 7.3 percent (6.9) · Earnings per share, SEK 2.56 (2.28) · Earnings per share before IAC, SEK 2.79 (2.60) · Cash flow from operating activities 106 percent (60) · The government business within SCIS to be closed down. Group operating margin adjusted for this business, 7.5 percent (7.1)* JANUARY–JUNE 2025 · Total sales MSEK 78

Hexagon Interim Report 1 January - 30 June 2025

Hexagon

—

2025

Second quarter 2025 − 3% organic revenue growth (using fixed exchange rates and a comparable group structure) − Net sales increased by 1% to 1,370.7 MEUR (1,353.4) − Net sales including the reduction of acquired deferred revenue amounted to 1,369.9 MEUR (1,353.4) − Adjusted gross margin of 67.0% (67.3) − Adjusted operating earnings (EBIT1) decreased by -10% to 360.6 MEUR (399.5) − Adjusted operating margin amounted to 26.3% (29.5) − Earnings per share, excluding adjustments, amounted to 9.8 Euro cent (10.8) − Earnings per share, including adjustments, amounted to 8.4 Euro cent (9.